qualgro seeding medium (BioIVT Inc)
Structured Review
Qualgro Seeding Medium, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/seeding+medium/qualgrotm+seeding+medium/pmc07543484-210-7-10
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes Article Snippet: Hepatocytes with viability over 90% were seeded at the density of 0.75 × 10 6 cells/well in 12-well collagen-coated plates using seeding Article Title: Mechanistic Modeling of the Hepatic Disposition of Estradiol-17 β -Glucuronide in Sandwich-Cultured Human Hepatocytes Article Snippet: QualGro TM seeding medium and Quantitative Proteomics:Article Title: Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes Article Snippet: Briefly, hepatocytes were thawed in Hepatocyte Thaw Medium (Life Technologies, Carlsbad, CA). .. Thawed hepatocytes were then plated in Incubation:Article Title: Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes Article Snippet: The following day (day 1), SCHH were established by overlaying the plated hepatocytes with Corning Matrigel® Matrix in QualGroTM Cell Culture Medium (BioIVT, Durham, NC). .. The following day (day 2), the SCHH were simultaneously incubated in Control:Article Title: Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes Article Snippet: The following day (day 1), SCHH were established by overlaying the plated hepatocytes with Corning Matrigel® Matrix in QualGroTM Cell Culture Medium (BioIVT, Durham, NC). .. The following day (day 2), the SCHH were simultaneously incubated in |
![IMNM autoantibodies induce hMMT <t>myotube</t> atrophy. A Representative 40x confocal images of myotubes formed in hMMTs within each condition immunostained for sarcomeric α-actinin (SAA, magenta) and counterstained with Hoechst 33,342 (cyan). Scale bar = 50 μm. B Dot plot of hMMT nuclear fusion index for individual hMMTs. C Dot plot of mean SAA positive coverage within flattened confocal stack images for individual hMMTs. D Dot plot of myotube width variation as quantified by the coefficient of variance for single myotubes. n = 146 for (+) and (-) healthy IgG, n = 138 for Ceri, n = 524 for anti-HMGCR, and n = 550 for anti-SRP. E Histogram illustrating myotube diameter frequency across treatment conditions. F Dot plot showing average myotube diameter for individual hMMTs. N = 7 patients for anti-HMGCR + and N = 7 for anti-SRP + IgG treatments. Cerivastatin (Ceri, 75 nM) treatment served as a positive control and no added IgG (-) or Healthy IgG treatment served as negative controls. n = 3 hMMTs per treatment condition. Samples were tested across N = 2 independent experiments which are distinguished in graphs by circle and triangle datapoints. Data for hMMTs treated with total IgGs are binned according to whether they induced a direct contractile effect (DCE; HP2-4 and SP5) or no contractile effect (NCE; HP1, 5–7 and SP1-4, 6, 7) on hMMT force production as indicated by the data in Fig. . All values are reported as means \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document} SEM; * p < 0.05,** p < 0.01, *** p < 0.001, and **** p < 0.0001](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2220/pmc12882220/pmc12882220__13395_2025_400_Fig3_HTML.jpg)
